Trend in seroprevalence of Hepatitis B virus infection among blood donors of coastal Karnataka, India

Journal of Infection in Developing Countries

Volumn 3, Issue 5, 2009, Pages 376-379

  Singh, Karandeep ^a   Bhat, Sudha ^a   Shastry, Shamee ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Blood donors; HBsAg; Seroprevalence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; SEROPREVALENCE; TERTIARY HEALTH CARE; WORLD HEALTH ORGANIZATION;

HEPATITIS B VIRUS;

ADULT; BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; INDIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 68049112217     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.246     Document Type: Article

References (15)

1. Prevention of hepatitis B in India, An overview. World Health Organization. New Delhi 2002.
2. Drugs and Cosmetics Act 1940 (India).
3. Nanu A, Sharma SP, Chatterjee K, Jyoti P (1997) Markers for transfusion-transmissible infections in North Indian voluntary and replacement blood donors: Prevalence and trends 1989-1996 Vox Sang 73: 70-73.
4. Pahuja S, Sharma M, Baitha B, Jain M (2007) Prevalence and trends of markers of Hepatitis C Virus, Hepatitis B Virus and Human Immunodeficiency Virus in Delhi blood donors: A Hospital Based Study. Jpn J Infect Dis 60: 389-391.
5. Singh B, Kataria SP, Gupta R. (2004) Infectious markers in blood donors of East Delhi: prevalence and trends. Indian J Pathol Microbiol. 47: 477-479.
6. Mathai J, Sulochana PV, Satyabhama S, Nair PK, Sivakumar S (2002) Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerala. Indian J Pathol Microbiol. 45: 319-322.
7. Chandrasekaran S, Palaniappan N, Krishnan V, Mohan G, Chandrasekaran N (2000) Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (anti HCV) in Madurai, South India. Indian J Med Sci. 54:270-273.
8. Sonwane BR, Birare SD, Kulkarni PV (2003) Prevalence of seroreactivity among blood donors in rural population. Indian J of Med Sci 57: 405-407
9. Singhvi A, Pulimood RB, John TJ, Babu PG, Samuel BU, Padankatti T, Carman RH (1990) The prevalence of markers for hepatitis B and human immunodeficiency viruses, malarial parasites and microfilaria in blood donors in a large hospital in south India. J Trop Med Hyg 93: 178-82.
10. Chattoraj A, Behl R, Kataria VK.(2008) Infectious Disease Markers in Blood Donors Medical journal Armed Forces of India. 64: 33-35
11. Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. (2007) Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: Exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol 21: 3730-3733.
12. Behal R, Jain R, Behal KK, Bhagoliwal A, Aggarwal N, Dhole TN (2008) Seroprevalence and risk factors for hepatitis B virus infection among general population in Northern India. Arq Gastroenterol. 45: 137-40.
13. Srikrishna A, Sitalakshmi S, Damodar P (1999) How safe are our safe donors? Indian J Pathol Microbiol. 42: 411-416.
14. Karki S, Ghimire P, Tiwari BR, Rajkarnikar M. (2008) HBsAg serosurveillance among Nepalese blood donors. Annals of Tropical Medicine and Public Health 1: 15-18.
15. Rodenas JG, Bacasen LC, Que ER. (2006) The prevalence of HBsAg(+) and anti HCV(+) among healthy blood donors at east avenue medical center, Quezon city. Phil J of Gastroenterology 2: 64-70.